Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
IN |
|
I
|
International Graphite Ltd
ASX:IG6
|
AU |
|
Katek Se
XETRA:KTEK
|
DE |
|
T
|
Trainers' House Oyj
OMXH:TRH1V
|
FI |
|
Amoeba SA
PAR:ALMIB
|
FR |
|
L
|
Leyand International Tbk PT
IDX:LAPD
|
ID |
|
SOL SpA
MIL:SOL
|
IT |
|
Torrid Holdings Inc
NYSE:CURV
|
US |
|
M
|
Mittel SpA
MIL:MIT
|
IT |
|
M
|
Metropole Television SA
F:MMT
|
FR |
|
G
|
Guangdong Bobaolon Co Ltd
SZSE:002776
|
CN |
|
A
|
Ampd Ventures Inc
CNSX:AMPD
|
CA |
|
Lotus Eye Hospital and Institute Ltd
NSE:LOTUSEYE
|
IN |
|
C
|
Copperwired PCL
SET:CPW
|
TH |
|
H
|
Hengan International Group Company Ltd
XMUN:HGNC
|
CN |
|
M
|
Monnari Trade SA
WSE:MON
|
PL |
|
K Car Co Ltd
KRX:381970
|
KR |
|
A
|
Anhui Zhongyuan New Materials Co Ltd
SSE:603527
|
CN |
Wall Street
Price Targets
ZYDUSLIFE Price Targets Summary
Zydus Lifesciences Ltd
According to Wall Street analysts, the average 1-year price target for
ZYDUSLIFE
is 1 015.8 INR
with a low forecast of 858.5 INR and a high forecast of 1 376.55 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ZYDUSLIFE's stock price target?
Price Target
1 015.8
INR
According to Wall Street analysts, the average 1-year price target for
ZYDUSLIFE
is 1 015.8 INR
with a low forecast of 858.5 INR and a high forecast of 1 376.55 INR.
What is Zydus Lifesciences Ltd's Revenue forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Zydus Lifesciences Ltd's revenue is
12%.
The projected
CAGR
for the next 3 years is
10%.
What is Zydus Lifesciences Ltd's Operating Income forecast?
Projected CAGR
0%
For the last 13 years the
compound annual growth rate for
Zydus Lifesciences Ltd's operating income is
15%.
The projected
CAGR
for the next 3 years is
0%.
What is Zydus Lifesciences Ltd's Net Income forecast?
Projected CAGR
1%
For the last 13 years the
compound annual growth rate for
Zydus Lifesciences Ltd's net income is
16%.
The projected
CAGR
for the next 3 years is
1%.
